Polycystic kidney disease (PKD) is most often diagnosed with an ultrasound that counts the number of fluid-filled cysts on each kidney. The specific number of cysts needed for a definitive diagnosis depends on your age and whether you have a family history of the disease. In many cases, PKD is discovered incidentally during imaging for an unrelated issue, or after a doctor investigates symptoms like high blood pressure, flank pain, or blood in the urine.
Ultrasound Is the First-Line Test
A standard kidney ultrasound is the go-to screening tool for the most common form of the disease, autosomal dominant polycystic kidney disease (ADPKD). It’s noninvasive, widely available, and reliable enough to confirm or rule out the diagnosis in most adults. That said, ultrasound has a notable limitation: it can’t reliably detect cysts smaller than 1 centimeter, and it’s highly dependent on the skill of the person performing it. For younger patients whose cysts haven’t had time to grow, a normal-looking ultrasound doesn’t necessarily mean the disease is absent.
How Many Cysts Confirm a Diagnosis
Doctors don’t just look for “some cysts.” There are specific thresholds based on your age, and these criteria assume you’re already considered at risk because a parent or close relative has the disease.
For people whose genetic type is unknown (the most common clinical scenario):
- Ages 15 to 39: 3 or more cysts total across one or both kidneys
- Ages 40 to 59: 2 or more cysts in each kidney
- Age 60 and older: 4 or more cysts in each kidney
The thresholds are higher for older adults because simple kidney cysts become common with age. A 65-year-old with two small cysts in one kidney likely has benign age-related cysts, not PKD. But a 20-year-old with three cysts almost certainly has the disease if a parent is affected.
When MRI or CT Is Used Instead
If ultrasound results are borderline or inconclusive, MRI provides a more detailed picture. It can detect smaller cysts and measure kidney size more precisely, making it especially useful in younger patients where cysts may be too small for ultrasound to catch. MRI criteria require higher cyst counts than ultrasound. For example, someone under 30 would need at least 5 cysts in each kidney on MRI to meet the diagnostic threshold.
MRI also plays a role in tracking how fast the disease is progressing. Doctors can measure total kidney volume, a metric that correlates strongly with future kidney function decline. The Mayo Clinic developed a classification system that sorts patients into five categories (1A through 1E) based on kidney volume adjusted for height and age. Someone in class 1A has slow-growing kidneys and a much better prognosis than someone in class 1E, where kidney volume is expanding rapidly. This classification helps guide treatment decisions, particularly whether to start medication that slows cyst growth.
Genetic Testing for Uncertain Cases
Most people with a known family history and clear imaging findings don’t need genetic testing. But there are specific situations where it becomes essential.
The most common scenario is evaluating a family member who wants to donate a kidney to a relative with PKD. Imaging may look completely normal in at-risk donors younger than 30, even if they carry the gene mutation. For potential donors under 30 with fewer than 3 cysts, or donors between 30 and 59 who have a few cysts that don’t clearly meet diagnostic criteria, genetic testing is recommended to make sure the donor won’t develop the disease later.
Genetic testing is also useful when there’s no known family history (about 10% of ADPKD cases arise from new mutations), when imaging is ambiguous, or when doctors need to distinguish PKD from other cystic kidney conditions. ADPKD is caused by mutations in two genes. Both appear to account for essentially all cases of the disease, though pinpointing the exact mutation can be technically challenging.
How the Recessive Form Is Diagnosed
Autosomal recessive polycystic kidney disease (ARPKD) is a rarer, more severe form that typically shows up before or shortly after birth. Prenatal ultrasound may reveal dramatically enlarged kidneys that appear unusually bright on imaging, along with low amniotic fluid levels. Low amniotic fluid is found in about 33% of all ARPKD cases and in 90% of those diagnosed before birth.
After delivery, the most severely affected newborns have kidneys so large they can be felt across the entire abdomen. Severe high blood pressure, sometimes resistant to treatment, affects up to 75 to 80% of children with ARPKD and can appear in the first months of life. The key ultrasound findings that suggest ARPKD in a child are kidneys that are larger than expected for age, increased brightness on imaging, and poor distinction between the inner and outer portions of the kidney. Genetic testing is recommended for infants with very early onset symptoms, particularly when no family history is known.
Liver Cysts as a Supporting Clue
Cysts don’t only grow in the kidneys. About 82% of adults with ADPKD also develop liver cysts, making them the most common finding outside the kidneys. These cysts increase with age and are more prevalent in males. While liver cysts alone don’t confirm a PKD diagnosis, finding them alongside kidney cysts strengthens the case, especially in borderline situations. Most liver cysts in PKD cause no symptoms and don’t affect liver function.
Screening Children and At-Risk Relatives
Whether to screen children of affected parents is a genuinely debated question among specialists. An international consensus statement recognizes two equally valid approaches: either test the child early with ultrasound or genetic analysis, or simply monitor blood pressure and urine protein regularly without pursuing a formal diagnosis. Both strategies require counseling beforehand so families understand what a positive result means for a condition that may not cause problems for decades.
Ultrasound remains the preferred imaging tool for screening children. Finding even one cyst in a child with an affected parent is highly suggestive of PKD. But a normal scan in childhood doesn’t rule the disease out, since cysts may not develop until the teenage years or later. For children with confirmed or suspected disease, regular monitoring of blood pressure (ideally with 24-hour ambulatory monitoring) and urine testing for protein are the recommended follow-up steps.